For: | Bilbao I, Dopazo C, Lazaro J, Castells L, Caralt M, Sapisochin G, Charco R. Multiple indications for everolimus after liver transplantation in current clinical practice. World J Transplant 2014; 4(2): 122-132 [PMID: 25032101 DOI: 10.5500/wjt.v4.i2.122] |
---|---|
URL: | https://www.wjgnet.com/2220-3230/full/v4/i2/122.htm |
Number | Citing Articles |
1 |
Christophe Duvoux, Christian Toso. mTOR inhibitor therapy: Does it prevent HCC recurrence after liver transplantation?. Transplantation Reviews 2015; 29(3): 168 doi: 10.1016/j.trre.2015.02.003
|
2 |
Jérôme Dumortier, Sebastien Dharancy, Yvon Calmus, Christophe Duvoux, François Durand, Ephrem Salamé, Faouzi Saliba. Use of everolimus in liver transplantation: The French experience. Transplantation Reviews 2016; 30(3): 161 doi: 10.1016/j.trre.2015.12.003
|
3 |
Kerstin Herzer, Christian P. Strassburg, Felix Braun, Cornelius Engelmann, Markus Guba, Frank Lehner, Silvio Nadalin, Andreas Pascher, Marcus N. Scherer, Andreas A. Schnitzbauer, Tim Zimmermann, Björn Nashan, Martina Sterneck. Selection and use of immunosuppressive therapies after liver transplantation: current German practice. Clinical Transplantation 2016; 30(5): 487 doi: 10.1111/ctr.12708
|
4 |
Itxarone Bilbao, Magdalena Salcedo, Miguel Angel Gómez, Carlos Jimenez, Javier Castroagudín, Joan Fabregat, Carolina Almohalla, Ignacio Herrero, Valentín Cuervas‐Mons, Alejandra Otero, Angel Rubín, Manuel Miras, Juan Rodrigo, Trinidad Serrano, Gonzalo Crespo, Manuel De la Mata, Javier Bustamante, M. Luisa Gonzalez‐Dieguez, Antonia Moreno, Isidoro Narvaez, Magda Guilera. Renal function improvement in liver transplant recipients after early everolimus conversion: A clinical practice cohort study in Spain. Liver Transplantation 2015; 21(8): 1056 doi: 10.1002/lt.24172
|
5 |
Angel Rubín Suárez, Itxarone Bilbao Aguirre, Javier Fernández-Castroagudin, José Antonio Pons Miñano, Magdalena Salcedo Plaza, Evaristo Varo Pérez, Martín Prieto Castillo. Recomendaciones de uso de everolimus en el trasplante hepático. Gastroenterología y Hepatología 2017; 40(9): 629 doi: 10.1016/j.gastrohep.2017.05.008
|
6 |
Angel Rubín Suárez, Itxarone Bilbao Aguirre, Javier Fernández-Castroagudin, José Antonio Pons Miñano, Magdalena Salcedo Plaza, Evaristo Varo Pérez, Martín Prieto Castillo. Recommendations of everolimus use in liver transplant. Gastroenterología y Hepatología (English Edition) 2017; 40(9): 629 doi: 10.1016/j.gastre.2017.10.006
|
7 |
Shin Hwang, Jung-Man Namgoong, Seak Hee Oh, Kyung Mo Kim, Chul-Soo Ahn, Hyunhee Kwon, Yu Jeong Cho, Yong Jae Kwon. Effect of everolimus rescue therapy for acute cellular rejection following pediatric living donor liver transplantation: Report of one case. Annals of Hepato-Biliary-Pancreatic Surgery 2020; 24(2): 216 doi: 10.14701/ahbps.2020.24.2.216
|
8 |
O. A. Gerasimova, D. A. Granov, F. K. Zherebtsov. Everolimus in clinical practice after liver transplantation: a single-center experience. Russian Journal of Transplantology and Artificial Organs 2017; 19(2): 34 doi: 10.15825/1995-1191-2017-2-34-40
|
9 |
Gonzalo Sapisochin, Jordi Bruix. Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches. Nature Reviews Gastroenterology & Hepatology 2017; 14(4): 203 doi: 10.1038/nrgastro.2016.193
|